PR release

Only FDA-approved neuroimmune modulation therapy for rheumatoid arthritis is now available to adults throughout New England.

TORONTO , Oct. 28, 2026 /CNW/ -- Calgary-based NanoTess today announced at the CAN Health Network Annual Conference that its proprietary catalytic technology, CTM, is now being deployed in Ukraine.

Hospital to become the only center in South Florida offering Inspire® therapy for pediatric patients with Down syndrome and obstructive sleep apnea

Companion Spine completes the integration of Paradigm Spine, unifying its portfolio of posterior dynamic stabilization and controlled motion technologies under its SMART Solutions™ strategy to address the continuum of lumbar spinal stenosis ("LSS") and degenerative disc disease ("DDD")

The expanded partnership brings in-home collection to ALCAT, Food Antibodies (IgG), Celiac panel, and GI/Celiac SNP genetic testing, reducing a common barrier for patients already managing GI symptoms.

HYDERABAD, India , Oct. 28, 2026 /PRNewswire/ -- According to the latest report by Mordor Intelligence, the hearing aids market size is estimated at USD 10.60 billion in 2026 and is projected to reach USD 13.34 billion by 2031 , registering a CAGR of 4.72% during the forecast period 2026-2031 . Market expansion is supported by the rising prevalence of hearing loss, an aging population, advancements in digital hearing technologies, and broader access to hearing care through prescription and over-the-counter (OTC) channels.

New and expanded relationships with key clinical partners will assist members to live healthier lives

SHERIDAN, Wyo. , Oct. 28, 2026 /PRNewswire/ -- How big is the infection control market, and what is driving its growth?

Expanded Executive and Advisor Team, including Jim DiCarlo, Dan Yamins and Stephen Wolfram, will Accelerate Development of Precision Therapies for Brain Disorders and Cognitive Enhancement

Designation recognizes the potential of Neurapheresis to offer advantages over existing treatment options following aneurysmal subarachnoid hemorrhage (aSAH)

MOUNT LAUREL TOWNSHIP, N.J. , Oct. 28, 2026 /PRNewswire/ -- The Wound, Ostomy, and Continence Nurses Society™ (WOCN ® ) today announced its support for the Access to Medical Supplies Act, H.R. 10787, bipartisan legislation that would exclude ostomy and urological supplies from Medicare's Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Competitive Bidding Program for five years. Building on its longstanding efforts to protect patient access to medically necessary supplies, the Society has prepared resources to help its 6,500+ members urge their representatives to cosponsor the bill.

HOPPR® FS MSK Whole-Body Narrative Model generates draft report findings from up to three X-ray views per study, with customization and integration available through HOPPR Forward Deployed Services

SEOUL, South Korea , Oct. 28, 2026 /PRNewswire/ -- Bright Eye Clinic has been honored with the "Ophthalmology Wellness Clinic of the Year in Korea" award at the 2026 GlobalHealth Asia-Pacific Awards , recognizing its sustained excellence in patient care and commitment to long-term eye health outcomes. This distinction highlights the clinic's unique position as a premier destination for international patients seeking advanced vision correction and cataract care in South Korea.

BOSTON , Oct. 28, 2026 /PRNewswire/ -- Empatica, a leader in digital biomarker development and clinical-grade wearable technology, today announced WellPD , an FDA-cleared and CE-marked wearable device and companion app for people with Parkinson's to monitor their symptoms at home.

Recognition highlights FDA approvals, improved patient outcomes, clinical evidence, integrated wound imaging, and commitment to customer support

Presented at ASRM 2026, the pilot study analyzed 375 days of combined hormone and wearable data, finding that Sleep and Readiness scores tended to be lowest around the LH surge.

Recognition highlights FDA approvals, improved patient outcomes, clinical evidence, integrated wound imaging, and commitment to customer support

Proprietary AI development engine turns clinical ideas into working models in weeks, accelerating the next generation of intelligent point-of-care ultrasound.

FREDERICK, Md. , Oct. 28, 2026 /PRNewswire/ -- CellectGen has received Small Business Innovation Research (SBIR) funding to develop a saliva-based, point-of-care diagnostic platform for periodontal disease, focused on early detection of active tissue destruction.

Test identifies UTI-causing bacteria and antibiotic resistance genes at the point of decision – helping clinicians choose the right antibiotic first time